(株)リボミックの貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4591/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2020/03/13日証協無担保2,900株+383.33%0株0%19,000株+40.42%
2020/03/13日証協有担保215,200株-36.8%36,900株-5.38%88,800株-28.39%
2020/03/06日証協無担保600株-81.82%0株0%13,531株-16.99%
2020/03/06日証協有担保340,499株+53.79%39,000株-10.66%124,000株+78.67%
2020/02/28日証協無担保3,300株+13.79%0株0%16,300株-3.03%
2020/02/28日証協有担保221,400株+51.54%43,654株+70.22%69,400株-36.56%
2020/02/21日証協無担保2,900株-50%0株0%16,810株+21.81%
2020/02/21日証協有担保146,100株-29.61%25,646株-56.09%109,400株-19.08%
2020/02/14日証協無担保5,800株-15.94%0株0%13,800株-55.77%
2020/02/14日証協有担保207,546株-69.61%58,400株+179.43%135,200株-58.75%
2020/02/07日証協無担保6,900株+283.33%0株0%31,200株+477.14%
2020/02/07日証協有担保682,895株+142.24%20,900株-82.85%327,746株+168.64%
2020/01/31日証協無担保1,800株+5.88%0株-100%5,406株-34.87%
2020/01/31日証協有担保281,912株-37.09%121,900株+2244.23%122,004株-28.02%
2020/01/24日証協無担保1,700株-48.48%330,000株0%8,300株-67.32%
2020/01/24日証協有担保448,112株-27.92%5,200株-96.03%169,500株-44.73%
2020/01/17日証協無担保3,300株0%0株0%25,400株+3.67%
2020/01/17日証協有担保621,658株+6.25%131,046株+836.04%306,700株+25.59%
2020/01/10日証協無担保0株0%0株0%24,500株+805.4%
2020/01/10日証協有担保585,074株+646.78%14,000株0%244,200株+293.24%
2019/12/30日証協無担保0株0%0株0%2,706株-87.36%
2019/12/30日証協有担保78,346株-62.97%0株-100%62,100株-39.41%
2019/12/27日証協無担保0株0%0株0%21,400株+230.15%
2019/12/27日証協有担保211,554株-48.64%11,162株+344.35%102,500株-71.83%
2019/12/20日証協無担保0株0%0株0%6,482株+1.11%
2019/12/20日証協有担保411,896株+34.07%2,512株+11.79%363,807株+117.22%
2019/12/13日証協無担保0株0%0株0%6,411株-54.53%
2019/12/13日証協有担保307,233株+7.88%2,247株+4061.11%167,484株-3.88%
2019/12/06日証協無担保0株0%0株0%14,100株+116.92%
2019/12/06日証協有担保284,800株+205.47%54株-98.48%174,246株+23.02%
2019/11/29日証協無担保0株0%0株0%6,500株-38.71%
2019/11/29日証協有担保93,233株-22.46%3,554株-3.95%141,646株+678.27%
2019/11/22日証協無担保0株0%0株0%10,606株-23.41%
2019/11/22日証協有担保120,233株-39.59%3,700株-92.16%18,200株-41.09%
2019/11/15日証協無担保0株0%0株0%13,847株+87.12%
2019/11/15日証協有担保199,033株+15.92%47,208株+13.13%30,892株-5.53%
2019/11/08日証協無担保0株0%0株0%7,400株-52.95%
2019/11/08日証協有担保171,700株-54.56%41,729株-57.03%32,700株-22.88%

※株式分割は考慮していませんのでご注意ください。

Page Top